Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate 35mg Weekly for Osteoporosis Prevention in Postmenopausal Women
NCT00402441Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2002
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate in osteoporosis, sponsored by Sanofi. Started Sep 2002; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00402441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402441.